Steroid Pulse Therapy Benefits GFAP Astrocytopathy - Takeaways - MDSpire

Steroid Pulse Therapy Benefits GFAP Astrocytopathy

Marked clinical and MRI improvement reported in a single-patient case.

  • By

  • Andrea Surnit

  • April 15, 2026

  • 2 min

Share

  • 1

    High-dose corticosteroid therapy led to significant clinical and neuroimaging improvement in a patient with autoimmune GFAP astrocytopathy.

  • 2

    The patient, a 19-year-old woman, exhibited subacute meningoencephalitic symptoms and characteristic MRI findings.

  • 3

    Cerebrospinal fluid analysis revealed lymphocytic pleocytosis with elevated protein and pressure, supporting the diagnosis.

  • 4

    Diagnosis of GFAP astrocytopathy relies on detecting GFAP antibodies in cerebrospinal fluid alongside clinical and imaging findings.

  • 5

    Tumor screening is advised post-diagnosis due to the potential association of GFAP astrocytopathy with underlying malignancies.

Original Source(s)

Steroid Pulse Therapy Benefits GFAP Astrocytopathy

  • by Andrea Surnit

  • April 15, 2026

Related Content

RSV-infected children with mixed infections: clinical features and early predictive indicators of codetection with Streptococcus pneumoniae and Haemophilus influenzae

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.

Perampanel use in pediatric autoimmune encephalitis-related seizures and epilepsy: a retrospective case series